RecruitingNot ApplicableNCT06878508
DuoCor Ventricular Assist System Early Feasibility Study
Clincial Use of Implantable Ventricular Assist System for Advanced Heart Failure
Sponsor
Shenzhen Core Medical Technology CO.,LTD.
Enrollment
10 participants
Start Date
Jul 4, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Feasibility study of the DuoCor Ventricular Assist System as a treatment for advanced total heart failure patients.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria4
- Requiring a biventricular mechanical circulatory support, defined by either of the following criteria:
- Persistent total heart failure despite under optimal medical management based on current heart failure practice guidelines. OR
- Development of refractory right heart failure following left ventricular assist device (LVAD) implantation, unresponsive to pharmacological interventions for right heart failure.
- Patient has signed the informed consent, has full understanding of procedures, and is committed to following study requirements.
Exclusion Criteria8
- Intolerance to anticoagulant or antiplatelet therapies or any other peri/post-operative therapy the investigator will require based upon the patient's health status.
- Technical obstacles which pose the implantation as unsuitable, obtaining the body type, body surface area, and anatomical conditions related to the planned implantation site, in the judgment of the experienced investigators.
- Pregnancy.
- Age \> 75 years.
- Presence of an active, uncontrolled infection.
- Brain death.
- History of confirmed, untreated abdominal aortic aneurysm (AAA) or thoracic aortic aneurysm (TAA) \> 5 cm in diameter.
- Irreversible cognitive dysfunction, psychosocial issues, or psychiatric disease, likely to impair compliance with the study protocol and DuoCor VAS management which, in the opinion of the investigator, could interfere with the ability to manage the therapy.
Interventions
DEVICEDuoCor Ventricular Assist System
The DuoCor VAS is used to provide hemodynamic support by shareing some or all the workload of the left and right ventricles during the support period.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06878508
Related Trials
Mind Your Heart-II
NCT054311921 location
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations